Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Total 13F shares
-
29,288,476
-
Share change
-
+4,905,799
-
Total reported value
-
$796,370,599
-
Put/Call ratio
-
13%
-
Price per share
-
$27.22
-
Number of holders
-
124
-
Value change
-
+$141,852,717
-
Number of buys
-
79
-
Number of sells
-
42
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2019
As of 30 Jun 2019 Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) had 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,288,476 shares of stock of the company.
Largest 10 holders included TRV GP III, LLC, Bellevue Group AG, Partner Fund Management, L.P., BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Casdin Capital, LLC, ARMISTICE CAPITAL, LLC, FARALLON CAPITAL MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 124 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.